CCS
CLX icon

Crosspoint Capital Strategies’s Clorox CLX Stock Holding History

Crosspoint Capital Strategies’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,314
Closed -$971K – 223
2015
Q4 		$971K Buy
9,314
+9,285
+32,017% +$1.15M 0.26% 106
2015
Q3 		$3K Buy
+29
New +$3.26K ﹤0.01% 558
2015
Q2 		– Sell
-600
Closed -$66K – 616
2015
Q1 		$66K Sell
600
-1,200
-67% -$130K 0.03% 244
2014
Q4 		$188K Buy
1,800
+1,000
+125% +$100K 0.07% 200
2014
Q3 		$77K Hold
800
– – 0.06% 181
2014
Q2 		$72K Hold
800
– – 0.03% 216
2014
Q1 		$70K Hold
800
– – 0.03% 226
2013
Q4 		$70K Buy
+800
New +$72.1K 0.02% 235

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CRC
Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
AI
Analytic Investors Los Angeles, California $8.93B AUM 13.54% 1-Year Est. Return

Crosspoint Capital Strategies's CLX Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Clorox (CLX) in Q1 2016, closing a stake of 9,314 shares — an estimated $971K sold.

Crosspoint Capital Strategies first reported a position in CLX in Q4 2013 and held it in 8 quarters. The position peaked at $971K in Q4 2015. 853 funds tracked by Wall St. Rank hold CLX as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Clorox position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 9,314 Clorox shares in Q1 2016, an estimated $971K.
  • Crosspoint Capital Strategies first reported a position in Clorox in Q4 2013 and held it in 8 quarters.
  • Crosspoint Capital Strategies's Clorox position peaked at $971K in Q4 2015.
  • 853 funds tracked by Wall St. Rank held Clorox as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.